BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BPX-601 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of BPX-601\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07543055-11298@assetmemo.bio
DTSTAMP:20261121T005558Z
DTSTART;VALUE=DATE:20300202
DTEND;VALUE=DATE:20300203
SUMMARY:BPX-601: Phase 1 readout est. (NCT07543055)
DESCRIPTION:BPX-601\, phase 1.\nStudy: A Phase 1 Study of BPX-601 CAR T-Cel
 l Therapy in Adult Participants With Prostate Cancer That Has Returned\, i
 s Resistant to Treatment and Has Spread\nEstimated primary completion: 2 F
 ebruary 2030. This is a ClinicalTrials.gov estimate\, not a confirmed read
 out date\, and it can move.\nDrug page: https://assetmemo.bio/drug/bpx-601
 #upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT075
 43055
URL:https://assetmemo.bio/drug/bpx-601#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
